Rochester Medical
This article was originally published in The Gray Sheet
Executive Summary
Divestiture of the firm's standard silicone Foley catheter business to Maersk Medical is called off after the firms fail to reach a definitive agreement. The April deal included the manufacturing operation and accompanying private label original equipment manufacturing rights for $12 mil. (1"The Gray Sheet" April 17, p. 20). The firm expects to introduce its hydrophilic Foley catheter, which was cleared May 19, shortly